| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51C ERCC2 ABCF1 DDX12P KIF26A NAIP SAE1 PSMC6 NUBP1 ATP13A5 ATP13A2 SWSAP1 CCT6A ACSM4 STARD9 ATP11A KIF18B SLC27A5 | 1.05e-06 | 614 | 152 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.44e-05 | 41 | 152 | 5 | GO:0016877 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC2 ABCF1 DDX12P KIF26A NAIP PSMC6 NUBP1 ATP13A5 ATP13A2 SWSAP1 CCT6A ATP11A KIF18B | 3.38e-05 | 441 | 152 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ligase activity | 5.72e-05 | 174 | 152 | 8 | GO:0016874 | |
| GeneOntologyMolecularFunction | calcium ion binding | SELE PLCZ1 FAT4 ADGRE2 RYR2 CAPN11 PITPNM1 EYS FAT2 FBN1 HMCN1 OTOF ADGRE3 PITPNM3 AGRN SYT13 NOTCH4 | 5.82e-05 | 749 | 152 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | chondroitin sulfate binding | 6.82e-05 | 11 | 152 | 3 | GO:0035374 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 8.65e-05 | 31 | 152 | 4 | GO:0016878 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | EEFSEC MTG1 ERCC2 ABCF1 DDX12P KIF26A NAIP PSMC6 NUBP1 ATP13A5 ATP13A2 TUFM GFM2 SWSAP1 CCT6A ATP11A KIF18B | 8.84e-05 | 775 | 152 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | EEFSEC MTG1 ERCC2 ABCF1 DDX12P KIF26A NAIP PSMC6 NUBP1 ATP13A5 ATP13A2 TUFM GFM2 SWSAP1 CCT6A ATP11A KIF18B | 2.27e-04 | 839 | 152 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | EEFSEC MTG1 ERCC2 ABCF1 DDX12P KIF26A NAIP PSMC6 NUBP1 ATP13A5 ATP13A2 TUFM GFM2 SWSAP1 CCT6A ATP11A KIF18B | 2.31e-04 | 840 | 152 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | EEFSEC MTG1 ERCC2 ABCF1 DDX12P KIF26A NAIP PSMC6 NUBP1 ATP13A5 ATP13A2 TUFM GFM2 SWSAP1 CCT6A ATP11A KIF18B | 2.31e-04 | 840 | 152 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | translation elongation factor activity | 4.48e-04 | 20 | 152 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.11e-04 | 51 | 152 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 6.85e-04 | 23 | 152 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 8.42e-04 | 323 | 152 | 9 | GO:1901681 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.11e-03 | 27 | 152 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 1.37e-03 | 29 | 152 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 1.37e-03 | 29 | 152 | 3 | GO:0043395 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | SELE ROBO4 FAT4 CD177 TAOK2 FAT2 PTPRD PTPRF HMCN1 PTPRS SDK1 | 1.37e-05 | 313 | 145 | 11 | GO:0098742 |
| Domain | EGF_3 | SELE FAT4 ADAM20 ADGRE2 EYS FAT2 FBN1 HMCN1 ADGRE3 AGRN NOTCH4 PEAR1 | 4.13e-07 | 235 | 149 | 12 | PS50026 |
| Domain | EGF_CA | 5.82e-07 | 122 | 149 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.68e-07 | 124 | 149 | 9 | IPR001881 | |
| Domain | EGF-like_dom | SELE FAT4 ADAM20 ADGRE2 EYS FAT2 FBN1 HMCN1 ADGRE3 AGRN NOTCH4 PEAR1 | 7.65e-07 | 249 | 149 | 12 | IPR000742 |
| Domain | EGF | SELE FAT4 ADGRE2 EYS FAT2 FBN1 HMCN1 ADGRE3 AGRN NOTCH4 PEAR1 | 2.98e-06 | 235 | 149 | 11 | SM00181 |
| Domain | EGF_1 | SELE FAT4 ADAM20 ADGRE2 EYS FAT2 FBN1 HMCN1 AGRN NOTCH4 PEAR1 | 6.50e-06 | 255 | 149 | 11 | PS00022 |
| Domain | EGF-like_CS | SELE FAT4 ADAM20 ADGRE2 EYS FAT2 FBN1 HMCN1 AGRN NOTCH4 PEAR1 | 8.11e-06 | 261 | 149 | 11 | IPR013032 |
| Domain | EGF_2 | SELE FAT4 ADAM20 ADGRE2 EYS FAT2 FBN1 HMCN1 AGRN NOTCH4 PEAR1 | 9.36e-06 | 265 | 149 | 11 | PS01186 |
| Domain | EGF_Ca-bd_CS | 1.26e-05 | 97 | 149 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.44e-05 | 99 | 149 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.54e-05 | 100 | 149 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.25e-05 | 106 | 149 | 7 | IPR000152 | |
| Domain | EGF_CA | 6.48e-05 | 86 | 149 | 6 | PF07645 | |
| Domain | IGc2 | 1.15e-04 | 235 | 149 | 9 | SM00408 | |
| Domain | Ig_sub2 | 1.15e-04 | 235 | 149 | 9 | IPR003598 | |
| Domain | G_TR_1 | 1.34e-04 | 13 | 149 | 3 | PS00301 | |
| Domain | - | 1.58e-04 | 64 | 149 | 5 | 3.40.50.1000 | |
| Domain | LAM_G_DOMAIN | 2.33e-04 | 38 | 149 | 4 | PS50025 | |
| Domain | Growth_fac_rcpt_ | 2.58e-04 | 156 | 149 | 7 | IPR009030 | |
| Domain | EFTu-like_2 | 3.72e-04 | 18 | 149 | 3 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 3.72e-04 | 18 | 149 | 3 | PF03144 | |
| Domain | G_TR_2 | 3.72e-04 | 18 | 149 | 3 | PS51722 | |
| Domain | P5-ATPase | 3.75e-04 | 4 | 149 | 2 | PF12409 | |
| Domain | LamG | 4.12e-04 | 44 | 149 | 4 | SM00282 | |
| Domain | HAD-like_dom | 4.24e-04 | 79 | 149 | 5 | IPR023214 | |
| Domain | TF_GTP-bd_dom | 4.39e-04 | 19 | 149 | 3 | IPR000795 | |
| Domain | EGF | 5.23e-04 | 126 | 149 | 6 | PF00008 | |
| Domain | - | 5.96e-04 | 21 | 149 | 3 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 5.96e-04 | 21 | 149 | 3 | IPR029045 | |
| Domain | NUT | 6.22e-04 | 5 | 149 | 2 | IPR024310 | |
| Domain | NUT_N | 6.22e-04 | 5 | 149 | 2 | IPR024309 | |
| Domain | NUT | 6.22e-04 | 5 | 149 | 2 | PF12881 | |
| Domain | P-type_TPase_V | 6.22e-04 | 5 | 149 | 2 | IPR006544 | |
| Domain | Ig_I-set | 8.40e-04 | 190 | 149 | 7 | IPR013098 | |
| Domain | I-set | 8.40e-04 | 190 | 149 | 7 | PF07679 | |
| Domain | LNS2 | 9.29e-04 | 6 | 149 | 2 | IPR013209 | |
| Domain | PI_transfer | 9.29e-04 | 6 | 149 | 2 | IPR001666 | |
| Domain | LNS2 | 9.29e-04 | 6 | 149 | 2 | SM00775 | |
| Domain | DDHD | 9.29e-04 | 6 | 149 | 2 | PF02862 | |
| Domain | DDHD | 9.29e-04 | 6 | 149 | 2 | PS51043 | |
| Domain | DDHD_dom | 9.29e-04 | 6 | 149 | 2 | IPR004177 | |
| Domain | LNS2 | 9.29e-04 | 6 | 149 | 2 | PF08235 | |
| Domain | LNS2/PITP | 9.29e-04 | 6 | 149 | 2 | IPR031315 | |
| Domain | DDHD | 9.29e-04 | 6 | 149 | 2 | SM01127 | |
| Domain | Laminin_G | 1.18e-03 | 58 | 149 | 4 | IPR001791 | |
| Domain | Transl_B-barrel | 1.26e-03 | 27 | 149 | 3 | IPR009000 | |
| Domain | hEGF | 1.41e-03 | 28 | 149 | 3 | PF12661 | |
| Domain | Ig-like_fold | ROBO4 ICAM3 CAMTA2 FCRL6 PTPRD PTPRF HMCN1 PTPRS PKHD1 LSAMP FLRT2 KIT SDK1 PLXNB1 | 1.57e-03 | 706 | 149 | 14 | IPR013783 |
| Domain | AMP-binding | 1.73e-03 | 30 | 149 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 1.73e-03 | 30 | 149 | 3 | IPR000873 | |
| Domain | Semap_dom | 1.90e-03 | 31 | 149 | 3 | IPR001627 | |
| Domain | SEMA | 1.90e-03 | 31 | 149 | 3 | PS51004 | |
| Domain | TIG | 1.90e-03 | 31 | 149 | 3 | PF01833 | |
| Domain | Sema | 1.90e-03 | 31 | 149 | 3 | SM00630 | |
| Domain | Sema | 1.90e-03 | 31 | 149 | 3 | PF01403 | |
| Domain | fn3 | 1.92e-03 | 162 | 149 | 6 | PF00041 | |
| Domain | IG | 2.06e-03 | 421 | 149 | 10 | SM00409 | |
| Domain | Ig_sub | 2.06e-03 | 421 | 149 | 10 | IPR003599 | |
| Domain | IPT | 2.08e-03 | 32 | 149 | 3 | IPR002909 | |
| Domain | - | 2.08e-03 | 32 | 149 | 3 | 3.40.1110.10 | |
| Domain | Plexin_repeat | 2.08e-03 | 32 | 149 | 3 | IPR002165 | |
| Domain | - | 2.08e-03 | 32 | 149 | 3 | 2.70.150.10 | |
| Domain | PSI | 2.08e-03 | 32 | 149 | 3 | PF01437 | |
| Domain | G_TR_CS | 2.19e-03 | 9 | 149 | 2 | IPR031157 | |
| Domain | - | ROBO4 ICAM3 FCRL6 PTPRD PTPRF HMCN1 PTPRS PKHD1 LSAMP FLRT2 KIT SDK1 PLXNB1 | 2.55e-03 | 663 | 149 | 13 | 2.60.40.10 |
| Domain | ATPase_P-typ_cyto_domN | 2.70e-03 | 35 | 149 | 3 | IPR023299 | |
| Domain | ENOYL_COA_HYDRATASE | 2.73e-03 | 10 | 149 | 2 | PS00166 | |
| Domain | ATPase_P-typ_P_site | 2.93e-03 | 36 | 149 | 3 | IPR018303 | |
| Domain | PTPc | 2.93e-03 | 36 | 149 | 3 | SM00194 | |
| Domain | P_typ_ATPase | 2.93e-03 | 36 | 149 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.93e-03 | 36 | 149 | 3 | PS00154 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYC RAD51C DNAJB11 ERCC2 DDX12P AIMP2 ACACA PDHB SAE1 SPART PSMC6 PFAS OAT PFKP TUFM STT3A CSDE1 CCT6A SF3B3 TRIM32 FIP1L1 ELP2 HADHA USP1 TBCD LRRC41 | 5.91e-11 | 1257 | 154 | 26 | 37317656 |
| Pubmed | EEFSEC RC3H2 ABCF1 ANGEL1 PFAS TUFM CSDE1 DIP2A TRIM32 ARHGEF7 TONSL YY1AP1 ELP2 AGRN PLXNB1 LRRC41 | 3.64e-08 | 650 | 154 | 16 | 38777146 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 8.51e-08 | 3 | 154 | 3 | 31985401 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 8.51e-08 | 3 | 154 | 3 | 33656439 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 28476886 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 9784606 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 IMPDH1 ACACA KIF26A THAP8 IPP PFAS CFAP43 ATP13A2 TAOK2 DIP2A HAUS4 PTPRF PTPRS COQ4 NEK8 ARHGAP44 PRDM16 AGRN TBCD | 1.05e-07 | 1105 | 154 | 20 | 35748872 |
| Pubmed | DNAJB11 ACACA SAE1 SPART PSMC6 PFAS OAT PFKP SUCLG2 CSDE1 BPNT1 XPNPEP3 HADHA PYCR3 | 1.26e-07 | 534 | 154 | 14 | 35032548 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC DNAJB11 ABCF1 AIMP2 ACACA PDHB SAE1 PSMC6 PFAS PFKP SUCLG2 TUFM CSDE1 CCT6A SF3B3 TRIM32 MIB1 FIP1L1 HADHA KIF18B AGRN PYCR3 | 1.47e-07 | 1353 | 154 | 22 | 29467282 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | DNAJB11 ACACA PDHB SAE1 PSMC6 OAT PFKP SUCLG2 TUFM STT3A CCT6A HADHA KIF18B PYCR3 | 2.50e-07 | 565 | 154 | 14 | 33567341 |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 8524829 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AIMP2 ACACA ATG13 HDAC8 NAIP APP STT3A CSDE1 KIDINS220 PTPRS EEPD1 ARHGAP44 XPNPEP3 CNDP2 TMPRSS2 ATP11A SEMA6A PNPLA7 LSM7 TBCD LRRC41 SOS2 | 7.39e-07 | 1489 | 154 | 22 | 28611215 |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 10777529 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 22357843 | ||
| Pubmed | ROBO4 ABCF1 AIMP2 ACACA SPART ZC3HC1 TUFM STT3A CSDE1 CCT6A SF3B3 FIP1L1 ELP2 HADHA | 1.39e-06 | 653 | 154 | 14 | 33742100 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ERCC2 ABCF1 AIMP2 ACACA PDHB SAE1 PSMC6 OAT SUCLG2 TUFM ADD1 STT3A CSDE1 CCT6A SF3B3 MIB1 CNDP2 HADHA AGRN PYCR3 | 1.65e-06 | 1318 | 154 | 20 | 30463901 |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 19273906 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RAD51C MTG1 DNAJB11 PDPR ACACA PDHB OAT PFKP TUFM GFM2 STT3A ECHDC3 HAUS4 FBN1 SF3B3 XPNPEP3 FIP1L1 HADHA PNPLA7 AGRN PYCR3 | 1.88e-06 | 1451 | 154 | 21 | 30550785 |
| Pubmed | DNAJB11 ABCF1 PDPR PDHB SPART PFAS OAT PFKP APP ADD1 STT3A DIP2A SF3B3 KIDINS220 MIB1 CNDP2 ELP2 SEMA6A HADHA PYCR3 LRRC41 | 2.75e-06 | 1487 | 154 | 21 | 33957083 | |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 12376545 | ||
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 29073098 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ERCC2 ABCF1 PDPR ACACA PDHB SAE1 PSMC6 PFAS PFKP SUCLG2 TUFM CCT6A ELP2 HADHA | 3.32e-06 | 704 | 154 | 14 | 29955894 |
| Pubmed | 3.43e-06 | 201 | 154 | 8 | 25192599 | ||
| Pubmed | 3.50e-06 | 52 | 154 | 5 | 26633812 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DNAJB11 ABCF1 AIMP2 ACACA PDHB SAE1 SPART PSMC6 PFAS PFKP TUFM ADD1 CCT6A SF3B3 XPNPEP3 FIP1L1 HADHA PYCR3 | 3.68e-06 | 1149 | 154 | 18 | 35446349 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SPAG1 PDHB ANGEL1 SPART PSMC6 STT3A CSDE1 ARHGEF7 ATP11A MFSD8 AGRN SYT13 TBCD CHST3 | 4.22e-06 | 719 | 154 | 14 | 35337019 |
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 37591863 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 28637841 | ||
| Pubmed | 5.64e-06 | 215 | 154 | 8 | 30462309 | ||
| Pubmed | 6.00e-06 | 288 | 154 | 9 | 38496616 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DNAJB11 ABCF1 PDHB ZNF618 TUFM STT3A CCT6A SF3B3 KIDINS220 TRIM32 ARHGEF7 XPNPEP3 FIP1L1 HADHA LSM7 AGRN PLXNB1 | 6.72e-06 | 1082 | 154 | 17 | 38697112 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SPAG1 ABCF1 PDPR ACACA PDHB SPART PSMC6 PFAS PFKP SUCLG2 TUFM STT3A CSDE1 CCT6A BPNT1 SF3B3 TRIM32 HADHA TBCD | 1.07e-05 | 1367 | 154 | 19 | 32687490 |
| Pubmed | ABCF1 AIMP2 IMPDH1 ACACA PDHB SAE1 PSMC6 PFAS OAT PFKP APP TUFM ADD1 CCT6A SF3B3 CNDP2 FIP1L1 HADHA | 1.12e-05 | 1247 | 154 | 18 | 27684187 | |
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 25624497 | ||
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 7832766 | ||
| Pubmed | 1.73e-05 | 251 | 154 | 8 | 29031500 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | DNAJB11 AIMP2 PDHB PFAS OAT PFKP SUCLG2 CSDE1 BPNT1 SF3B3 HADHA TBCD | 1.81e-05 | 607 | 154 | 12 | 39147351 |
| Pubmed | 1.82e-05 | 12 | 154 | 3 | 20808825 | ||
| Pubmed | 1.82e-05 | 12 | 154 | 3 | 21965664 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 1.82e-05 | 12 | 154 | 3 | 9624153 | |
| Pubmed | EEFSEC DNAJB11 ABCF1 AIMP2 PDHB PSMC6 OAT TUFM GFM2 ADD1 STT3A FIP1L1 PYCR3 | 1.83e-05 | 711 | 154 | 13 | 33022573 | |
| Pubmed | Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production. | 1.95e-05 | 2 | 154 | 2 | 20059989 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21381019 | ||
| Pubmed | Early induction of c-Myc is associated with neuronal cell death. | 1.95e-05 | 2 | 154 | 2 | 22005580 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 35045360 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 7665159 | ||
| Pubmed | The role of mast cells in the development of skin fibrosis in tight-skin mutant mice. | 1.95e-05 | 2 | 154 | 2 | 7704626 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 33548010 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 38982480 | ||
| Pubmed | Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice. | 1.95e-05 | 2 | 154 | 2 | 20941644 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32966798 | ||
| Pubmed | NEK8 regulates colorectal cancer progression via phosphorylating MYC. | 1.95e-05 | 2 | 154 | 2 | 37596667 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17906636 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9566880 | ||
| Pubmed | 2.05e-05 | 257 | 154 | 8 | 16335952 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | DNAJB11 PSMC6 PFKP APP STT3A CCT6A PTPRF TRIM32 PTPRS HADHA PYCR3 | 2.06e-05 | 516 | 154 | 11 | 36610398 |
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 2.36e-05 | 13 | 154 | 3 | 15491607 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DNAJB11 ABCF1 AIMP2 IMPDH1 ACACA PDHB SAE1 PSMC6 ZC3HC1 NUBP1 PFAS PFKP TUFM CSDE1 CCT6A CNDP2 ELP2 PYCR3 TBCD | 2.53e-05 | 1455 | 154 | 19 | 22863883 |
| Pubmed | SATB2 PDPR KIF26A SPART TAOK2 SF3B3 ARHGEF7 MIB1 NDRG4 SYT13 PLXNB1 | 2.58e-05 | 529 | 154 | 11 | 14621295 | |
| Pubmed | 2.96e-05 | 197 | 154 | 7 | 31620119 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DNAJB11 TRAF3 PDHB SAE1 PSMC6 PFAS OAT PFKP STT3A KIDINS220 PTPRD PTPRF TRIM32 PTPRS PYCR3 | 3.03e-05 | 974 | 154 | 15 | 28675297 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.35e-05 | 358 | 154 | 9 | 32460013 | |
| Pubmed | 3.63e-05 | 42 | 154 | 4 | 24997765 | ||
| Pubmed | 3.73e-05 | 15 | 154 | 3 | 18303054 | ||
| Pubmed | PDHB NUTM2A SAE1 SPART ZC3HC1 OAT SUCLG2 STT3A CCT6A NUTM2B CNDP2 HADHA PYCR3 TBCD | 3.88e-05 | 878 | 154 | 14 | 37223481 | |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 3.97e-05 | 282 | 154 | 8 | 35007762 | |
| Pubmed | DNAJB11 ABCF1 ACACA PDHB OAT APP RYR2 TAOK2 PITPNM1 CSDE1 CCT6A ARHGEF7 PITPNM3 CNDP2 HADHA NDRG4 | 4.90e-05 | 1139 | 154 | 16 | 36417873 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 5.46e-05 | 91 | 154 | 5 | 28558017 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 5.53e-05 | 17 | 154 | 3 | 19727691 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 38031136 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 36228617 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 20395454 | ||
| Pubmed | Shear stress-regulated miR-27b controls pericyte recruitment by repressing SEMA6A and SEMA6D. | 5.83e-05 | 3 | 154 | 2 | 28453731 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 26803058 | ||
| Pubmed | Pitpnm1 is expressed in hair cells during development but is not required for hearing. | 5.83e-05 | 3 | 154 | 2 | 23820044 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 38987435 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 31501481 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 18753147 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 24458279 | ||
| Pubmed | SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer. | 5.83e-05 | 3 | 154 | 2 | 26701851 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 19923370 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 21224067 | ||
| Pubmed | Amyloid beta induces cellular relocalization and production of agrin and glypican-1. | 5.83e-05 | 3 | 154 | 2 | 19166823 | |
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 5.83e-05 | 3 | 154 | 2 | 26542179 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 25027320 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 22456610 | ||
| Pubmed | c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming. | 5.83e-05 | 3 | 154 | 2 | 36629054 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 25703008 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 34609281 | ||
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 5.83e-05 | 3 | 154 | 2 | 25394468 | |
| Pubmed | Key roles for MYC, KIT and RET signaling in secondary angiosarcomas. | 5.83e-05 | 3 | 154 | 2 | 24983371 | |
| Pubmed | Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity. | 5.83e-05 | 3 | 154 | 2 | 15797869 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 15627748 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 26586575 | ||
| Pubmed | Hypertension genes and retinal vascular calibre: the Cardiovascular Health Study. | 5.83e-05 | 3 | 154 | 2 | 19148102 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 37017854 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 36208707 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 21113618 | ||
| Pubmed | PDHB SAE1 PSMC6 OAT PFKP SUCLG2 TUFM CCT6A SF3B3 CNDP2 HADHA AGRN SOS2 | 6.36e-05 | 803 | 154 | 13 | 36517590 | |
| Interaction | C9orf72 interactions | MYC RAD51C DNAJB11 ERCC2 DDX12P AIMP2 ACACA PDHB ATG13 SAE1 SPART PSMC6 PFAS OAT PFKP APP TUFM STT3A CSDE1 CCT6A SF3B3 TRIM32 FIP1L1 ELP2 HADHA USP1 TBCD LRRC41 | 3.69e-07 | 1319 | 149 | 28 | int:C9orf72 |
| Interaction | TOP3B interactions | RC3H2 ERCC2 IMPDH1 ACACA KIF26A THAP8 IPP PFAS CFAP43 PFKP APP ATP13A2 TUFM TAOK2 CSDE1 DIP2A HAUS4 PTPRF PTPRS COQ4 NEK8 ARHGAP44 MIB1 HADHA PRDM16 AGRN TBCD | 9.41e-06 | 1470 | 149 | 27 | int:TOP3B |
| Interaction | BCAT2 interactions | 1.25e-05 | 41 | 149 | 5 | int:BCAT2 | |
| Interaction | ECH1 interactions | 1.93e-05 | 253 | 149 | 10 | int:ECH1 | |
| Interaction | EGLN3 interactions | DNAJB11 PDPR ACACA PDHB ANGEL1 SAE1 PSMC6 NUBP1 PFAS SUCLG2 TUFM STT3A TAOK2 CCT6A HAUS4 KIDINS220 ADRB2 TONSL MIB1 ELP2 HADHA LSM7 PYCR3 LRRC41 | 2.78e-05 | 1296 | 149 | 24 | int:EGLN3 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.92e-05 | 161 | 99 | 7 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.97e-04 | 21 | 99 | 3 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 2.49e-04 | 160 | 99 | 6 | 555 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 2.94e-04 | 5 | 99 | 2 | 915 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 2.94e-04 | 5 | 99 | 2 | 1213 | |
| GeneFamily | SEC14 family|PRELI domain containing | 4.39e-04 | 6 | 99 | 2 | 1063 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 4.39e-04 | 6 | 99 | 2 | 1151 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.04e-03 | 46 | 99 | 3 | 622 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.98e-03 | 15 | 99 | 2 | 26 | |
| GeneFamily | Cadherin related | 3.83e-03 | 17 | 99 | 2 | 24 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 5.29e-03 | 20 | 99 | 2 | 736 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.09e-08 | 174 | 155 | 9 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-08 | 186 | 155 | 9 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-08 | 186 | 155 | 9 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-08 | 190 | 155 | 9 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-08 | 191 | 155 | 9 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-08 | 192 | 155 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.67e-08 | 193 | 155 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 194 | 155 | 9 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-08 | 194 | 155 | 9 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-08 | 194 | 155 | 9 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-07 | 175 | 155 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-07 | 182 | 155 | 8 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 187 | 155 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-07 | 189 | 155 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.39e-07 | 189 | 155 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-07 | 191 | 155 | 8 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.68e-07 | 191 | 155 | 8 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-07 | 192 | 155 | 8 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-07 | 194 | 155 | 8 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.30e-07 | 195 | 155 | 8 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.65e-07 | 197 | 155 | 8 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.65e-07 | 197 | 155 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.83e-07 | 198 | 155 | 8 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.83e-07 | 198 | 155 | 8 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.83e-07 | 198 | 155 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.02e-07 | 199 | 155 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 200 | 155 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.45e-06 | 159 | 155 | 7 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-06 | 179 | 155 | 7 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.30e-06 | 180 | 155 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 181 | 155 | 7 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-06 | 181 | 155 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.42e-06 | 181 | 155 | 7 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-06 | 185 | 155 | 7 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.95e-06 | 185 | 155 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-06 | 185 | 155 | 7 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-06 | 186 | 155 | 7 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.09e-06 | 186 | 155 | 7 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-06 | 186 | 155 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 190 | 155 | 7 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-06 | 190 | 155 | 7 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 4.71e-06 | 190 | 155 | 7 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 4.71e-06 | 190 | 155 | 7 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-06 | 190 | 155 | 7 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.87e-06 | 191 | 155 | 7 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-06 | 191 | 155 | 7 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-06 | 191 | 155 | 7 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-06 | 191 | 155 | 7 | 0e6cd2628a5cebd35e960e4eb3b52ddc9358031c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-06 | 191 | 155 | 7 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-06 | 191 | 155 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 193 | 155 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 193 | 155 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 5.22e-06 | 193 | 155 | 7 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 193 | 155 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 193 | 155 | 7 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.22e-06 | 193 | 155 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-06 | 194 | 155 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-06 | 194 | 155 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.40e-06 | 194 | 155 | 7 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-06 | 194 | 155 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 194 | 155 | 7 | faaa7f18667e8943528fd0e92b7988e5b0607b54 | |
| ToppCell | facs-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-06 | 194 | 155 | 7 | 3b5ba12375102598468cb09e66af9241b66c3cf9 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-06 | 194 | 155 | 7 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-06 | 194 | 155 | 7 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.58e-06 | 195 | 155 | 7 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-06 | 195 | 155 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-06 | 195 | 155 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.58e-06 | 195 | 155 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.58e-06 | 195 | 155 | 7 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.77e-06 | 196 | 155 | 7 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 196 | 155 | 7 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.77e-06 | 196 | 155 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.77e-06 | 196 | 155 | 7 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 5.77e-06 | 196 | 155 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.97e-06 | 197 | 155 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | tumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 5.97e-06 | 197 | 155 | 7 | 6870b311c54a73723768276a58456620f5217d43 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-06 | 197 | 155 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.97e-06 | 197 | 155 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-06 | 197 | 155 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-06 | 197 | 155 | 7 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.97e-06 | 197 | 155 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-06 | 197 | 155 | 7 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | Endothelial-A|World / lung cells shred on cell class, cell subclass, sample id | 6.17e-06 | 198 | 155 | 7 | dd096d4b9f428615f927f7df7cbf5cede0e0e605 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.17e-06 | 198 | 155 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 6.17e-06 | 198 | 155 | 7 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.17e-06 | 198 | 155 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.17e-06 | 198 | 155 | 7 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 6.17e-06 | 198 | 155 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.17e-06 | 198 | 155 | 7 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.17e-06 | 198 | 155 | 7 | 56b746e5791b47fe33a7872f0942ae0747b13d4a | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.17e-06 | 198 | 155 | 7 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.37e-06 | 199 | 155 | 7 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.37e-06 | 199 | 155 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.37e-06 | 199 | 155 | 7 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.37e-06 | 199 | 155 | 7 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| Drug | phenylthiocarbamide | 7.32e-07 | 76 | 151 | 7 | CID000676454 | |
| Disease | Ciliopathies | 2.42e-05 | 110 | 153 | 6 | C4277690 | |
| Disease | interstitial lung disease | 2.62e-05 | 67 | 153 | 5 | EFO_0004244 | |
| Disease | glycerate measurement | 5.94e-05 | 15 | 153 | 3 | EFO_0021029 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 7.33e-05 | 43 | 153 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | Disorder of eye | 1.25e-04 | 212 | 153 | 7 | C0015397 | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 1.59e-04 | 4 | 153 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 1.59e-04 | 4 | 153 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | Alzheimer disease, polygenic risk score | ERCC2 ATG13 MUC19 ECHDC3 SF3B3 SLC24A4 PKHD1 LSAMP HADHA FLRT2 SDK1 | 2.54e-04 | 586 | 153 | 11 | EFO_0030082, MONDO_0004975 |
| Disease | Endometrial Stromal Sarcoma | 2.64e-04 | 5 | 153 | 2 | C0206630 | |
| Disease | azoospermia (implicated_via_orthology) | 3.65e-04 | 27 | 153 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Clear cell sarcoma of kidney | 3.95e-04 | 6 | 153 | 2 | C0334488 | |
| Disease | Hirschsprung's disease (is_marker_for) | 3.95e-04 | 6 | 153 | 2 | DOID:10487 (is_marker_for) | |
| Disease | lumbar disc degeneration | 4.07e-04 | 28 | 153 | 3 | EFO_0004994 | |
| Disease | susceptibility to mononucleosis measurement | 4.62e-04 | 69 | 153 | 4 | EFO_0008403 | |
| Disease | Aortic Aneurysm, Thoracic | 5.51e-04 | 7 | 153 | 2 | C0162872 | |
| Disease | Aortic Aneurysm, Thoracoabdominal | 5.51e-04 | 7 | 153 | 2 | C0340630 | |
| Disease | fatty liver disease (is_implicated_in) | 5.51e-04 | 7 | 153 | 2 | DOID:9452 (is_implicated_in) | |
| Disease | blood viscosity | 5.52e-04 | 31 | 153 | 3 | EFO_0004301 | |
| Disease | skin pigmentation measurement | 7.57e-04 | 137 | 153 | 5 | EFO_0007009 | |
| Disease | late-onset Alzheimers disease | 8.58e-04 | 292 | 153 | 7 | EFO_1001870 | |
| Disease | Hereditary Diffuse Gastric Cancer | 8.75e-04 | 293 | 153 | 7 | C1708349 | |
| Disease | obesity (implicated_via_orthology) | 9.26e-04 | 215 | 153 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Stomach Neoplasms | 9.46e-04 | 297 | 153 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.00e-03 | 300 | 153 | 7 | C0024623 | |
| Disease | biological sex | 1.31e-03 | 230 | 153 | 6 | PATO_0000047 | |
| Disease | Machado-Joseph disease, age at onset | 1.42e-03 | 11 | 153 | 2 | EFO_0004847, MONDO_0007182 | |
| Disease | phosphatidylcholine 32:0 measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0010372 | |
| Disease | Cystic Kidney Diseases | 1.42e-03 | 11 | 153 | 2 | C1691228 | |
| Disease | Nephronophthisis | 2.01e-03 | 13 | 153 | 2 | C0687120 | |
| Disease | smoking behavior | 2.08e-03 | 341 | 153 | 7 | EFO_0004318 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 2.33e-03 | 14 | 153 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 2.33e-03 | 14 | 153 | 2 | C1960469 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | hemorheological measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0803374 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.06e-03 | 16 | 153 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 3.42e-03 | 58 | 153 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Malignant neoplasm of skin | 3.59e-03 | 59 | 153 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.59e-03 | 59 | 153 | 3 | C0037286 | |
| Disease | serum IgG measurement | 3.87e-03 | 18 | 153 | 2 | EFO_0004565 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 3.87e-03 | 18 | 153 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | colorectal health | 4.05e-03 | 201 | 153 | 5 | EFO_0008460 | |
| Disease | exercise test | 4.77e-03 | 20 | 153 | 2 | EFO_0004328 | |
| Disease | age at initiation of smoking | 4.93e-03 | 66 | 153 | 3 | EFO_0021784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FILPQNGVVEDVCVM | 131 | Q7L8C5 | |
| CVVPGAGAVEVAMAE | 406 | P40227 | |
| PEVFGNLNSVMCVEG | 456 | Q13075 | |
| FGIDMDSRICIVGPN | 646 | Q8NE71 | |
| ACADLVMGLAVVPFG | 76 | P07550 | |
| GQLPAVGRSMCVEIS | 71 | O75143 | |
| GIVGVMATNIPCEVV | 66 | Q8NDM7 | |
| CVVNEGMLTGESIPV | 306 | Q4VNC0 | |
| AGLLAEPQIAMFCGR | 26 | P05067 | |
| CLGILQVGPAARVMA | 746 | Q9UHX3 | |
| TPDIMCGRVQCENVG | 556 | O43506 | |
| CGNMAGRIEFNPIRV | 251 | Q9H175 | |
| VGCIMEFAVNGRPLE | 4131 | Q6V0I7 | |
| PQGAVRDDCEQMTGL | 851 | O00468 | |
| RMAEIAAAGQVPCQG | 651 | O94983 | |
| VQAERPDTMLGVVCG | 621 | Q13085 | |
| PEERMNGQVVCAVPH | 96 | O75534 | |
| NVACIRTGIIFMPGT | 131 | P0C7M7 | |
| EAQQRVGGCFLNLMP | 341 | Q14155 | |
| TQEIGPVGMTENCNR | 191 | Q8N6Q3 | |
| FIMDGISPTDICQGI | 121 | Q9UMQ6 | |
| AGDIFAEVMVCRVLP | 81 | Q9H8S5 | |
| GNLMVVQPDRIRCGA | 176 | Q6ZUJ8 | |
| CVAAMNPDAVLRVGG | 206 | O95861 | |
| AGLAVDCVRQAQPAM | 131 | Q9UMX3 | |
| GASAGVLMIQPCALD | 226 | A6NI87 | |
| SLNVRGFMCQGPEQV | 331 | O43155 | |
| ANNPGVREVVCMTLL | 276 | Q7L9B9 | |
| REMLPQQVGFVCAVL | 16 | Q8NFF2 | |
| PDCMASLIVARQGLG | 501 | Q8NFF2 | |
| ARGCQFLGPAMQEEA | 186 | Q9HBD1 | |
| MQLAVDVQIPECFGG | 136 | O43502 | |
| VPRAGMCVVAVNGLL | 521 | Q9Y573 | |
| NISMCQALGFILGPV | 171 | Q8NHS3 | |
| LPIIGVVENMSGFIC | 221 | P53384 | |
| VGAEICARIMEGPAF | 301 | P11177 | |
| ECGQTPLMIAAEQGN | 36 | Q9ULH0 | |
| MAIENEPVGFQGCIR | 2856 | Q5T1H1 | |
| LVNGMLQCVAAGFPE | 421 | P10721 | |
| SDLNFMRGVACVIPG | 1171 | Q86VF7 | |
| GDMVQLLCEAQRGSP | 221 | Q6DN72 | |
| PVIAMVNGLAAAAGC | 141 | Q96DC8 | |
| NLEYCIMVIGVPNVG | 141 | Q9BT17 | |
| DVLGMVTVAGVPCAV | 1101 | O43157 | |
| MGNTSLVVPENCRGL | 3871 | Q9NYQ8 | |
| GMVRNSKGICVFPND | 1221 | Q7Z5P9 | |
| SMALPTQAQVVICGG | 36 | Q8NCN5 | |
| CNVAVINVGAPAAGM | 411 | Q01813 | |
| GAPCRIGIQEPFTVM | 731 | Q5VY43 | |
| CTMEVTPGAEIQDGR | 216 | Q6UN15 | |
| MPPGQEAQRVVCGID | 491 | Q86SG6 | |
| EEGFMLQGPAQVECT | 336 | P16581 | |
| CPMIIGRGNDQVAIS | 491 | P18074 | |
| MVGRGVPLCAAQPAV | 1 | Q9ULI4 | |
| RVLDVATCPGINMAA | 181 | Q8WV35 | |
| NMITGTAPLDGCILV | 136 | P49411 | |
| TPGCVIAAARILQNM | 91 | Q495T6 | |
| LGGNCRTVMIAAISP | 316 | Q86Y91 | |
| ELSLGIGCPVNMVEV | 51 | A0A2R8YFL7 | |
| DTCLFLTRPGEMVGQ | 516 | Q6ZV29 | |
| EGNAVEIIMCNIRPC | 4626 | Q96RW7 | |
| SQGVGRPCMDINECE | 5306 | Q96RW7 | |
| CMAGARVQVTLDGVP | 336 | P32942 | |
| CITQEVMACGRPQGT | 331 | P20839 | |
| DGTMCDTCRQQPIIG | 81 | Q86YT6 | |
| IMPGGNVNITCVAVG | 256 | Q13332 | |
| GVNCFMLDPAIGEFI | 181 | P09467 | |
| QPQDVMCSIGVVDQG | 891 | Q52LW3 | |
| TAVTVARGCGMVAPQ | 756 | Q9NQ11 | |
| GCVVQASGLFPAEMR | 86 | Q494R0 | |
| QDRGAGPRVEMICQA | 136 | Q6UX52 | |
| DQLICSLQREGMGSP | 166 | Q96M11 | |
| REIPGVCENGVCINM | 1771 | P35555 | |
| EAVQTGLPMCILGAF | 186 | Q9Y3A0 | |
| ECRAVVIAGGTMQPV | 631 | Q92771 | |
| MVVSSAIGCQLGRDP | 261 | Q9BRF8 | |
| GPGRFQMTQEVVCDE | 181 | Q9UBS4 | |
| CRGTSVVLICPQDGM | 76 | Q9UK45 | |
| VMCLQEGILATPAEG | 686 | P40939 | |
| PLQAGDTVCVDLVMG | 976 | Q9Y6C2 | |
| GPEVMCLQTLNFGNG | 146 | Q6IA86 | |
| VQDVGQVMPGANVCV | 716 | Q14689 | |
| VLQLGADTIAGDPMC | 261 | Q9BY41 | |
| FCSPGEGMEILQQVC | 6 | Q9H6D7 | |
| MVPEDGSLTCLQAGV | 346 | Q9UDX3 | |
| MVPEDGILTCLQAGS | 346 | B5MCN3 | |
| EETVDIGCQAMGVPL | 401 | Q7Z5N4 | |
| ITPMLRGDVQCFGED | 201 | Q16348 | |
| PVVEDVMTAGNCGNT | 351 | Q9Y2B1 | |
| FIPVCSLGVAQVGRM | 1201 | Q92736 | |
| GPRNCIGQSFAMAEL | 471 | Q6NT55 | |
| LVGLNMDPVVCVEVG | 266 | Q9HC10 | |
| QEVMPGGSVNLTCVA | 241 | P10586 | |
| EIMPGGSVNITCVAV | 246 | P23468 | |
| GILGMLCQDPDRATQ | 636 | Q6ZUA9 | |
| PVMAAQVVGGTQACE | 256 | Q8IVF1 | |
| PVMAAQVVGGTQACE | 256 | A6NNL0 | |
| PVMAAQVVGGTQACE | 256 | B1AL46 | |
| PLSVAMNCQGLIGVT | 431 | Q13049 | |
| QTFTIICGGPDIAMV | 236 | Q8NA92 | |
| VRLDPDSGQTVLCGM | 521 | Q969S9 | |
| RIVDGMFAVCGVPES | 216 | P49590 | |
| GQCCNEFIMEGPLTR | 436 | Q07890 | |
| AAPAICNGMLQGILS | 196 | Q8IYP2 | |
| CGNMSEAFREAGIQP | 36 | P08582 | |
| ENCLEQLEMGFPRGA | 586 | Q15345 | |
| GSNVTLVCMANGRPE | 146 | Q13449 | |
| IGCQMVALNFQTPGL | 426 | Q86YW0 | |
| LGGDMVNQSFICDPD | 106 | P01106 | |
| ADMQIVDGSAQCPGL | 1096 | Q9HAZ2 | |
| GGLMIPVFCVVEQLD | 56 | Q9UPW6 | |
| APVMCILSGIGVSQV | 411 | P46977 | |
| GMISRALFPDEVGCV | 336 | Q2M3M2 | |
| CSPGQEAVLDQRMLG | 776 | Q9UL54 | |
| FSEMAPVCAVVGGIL | 296 | Q9UBE0 | |
| RCPVMLVVGDNAPAE | 226 | Q9ULP0 | |
| PGRDCGLMVALQTQE | 131 | Q6NVH7 | |
| ANIDIFIGMSPCVGV | 1681 | P08F94 | |
| ADGTFQGRCIPDMTQ | 1436 | Q9P2P6 | |
| FVVVMGVDLSRCGPD | 1381 | Q99466 | |
| ECGMQEEGLFRVAPS | 281 | Q17R89 | |
| VLPMNTGVEAGETAC | 136 | P04181 | |
| NLPCVVQEGAIVMAR | 126 | Q53H96 | |
| MVAVVGEQFTLECGP | 146 | Q8WZ75 | |
| CLGLLQVGPAAQVMA | 566 | Q9BY15 | |
| IQTMCPIEGEGNIAR | 201 | Q13155 | |
| TAGPQSQVLCGVVMD | 516 | P35611 | |
| ACQRPVGLVLMEGVT | 521 | Q9UNK9 | |
| LAQVVQAACGPAMRL | 436 | Q7LGC8 | |
| GQEIPVNVRFCLEGM | 151 | Q96KP4 | |
| ICNGQVLPESSGIDM | 441 | P98196 | |
| MAAPCEGQAFAVGVE | 1 | Q86WB0 | |
| VVCEGRPQVLSGRFM | 926 | O00562 | |
| ILMDRSCNGPVLVGS | 156 | Q96I99 | |
| PITSAMQGDRLGICV | 276 | P57772 | |
| MQGDRLGICVTQFDP | 281 | P57772 | |
| PDTMLQAAGCFVGVV | 296 | Q8N0X7 | |
| GEMNIASGCPVFVAQ | 526 | Q13114 | |
| TPAMICAGFLQGNVD | 421 | O15393 | |
| LAVPAVGARSGCVNM | 911 | Q5T7W0 | |
| CVNLVMGVVGPSSVA | 2641 | Q8N2C7 | |
| EIIVNQACGGDMPAL | 71 | Q9H0X6 | |
| MEAAEPVRDNQGFCI | 471 | Q9Y2P5 | |
| EAEGRDPQGAMVICE | 301 | Q96HA7 | |
| DPQGAMVICEQLGDL | 306 | Q96HA7 | |
| FPRVAQVCKNDMGGS | 251 | Q9H2E6 | |
| EMAFAGNCGLQVDVP | 921 | O15067 | |
| AGAARAAQPCVMGNI | 371 | Q07617 | |
| VGVDVGFENPMFACL | 171 | Q15393 | |
| VLPRGMECVVFSIDG | 731 | Q9BZ71 | |
| VSLGGGCNMIQPVNA | 611 | Q9H869 | |
| VPAVANVRGLSGCML | 11 | Q9NQH7 | |
| QPCIIFMDEIDAIGG | 226 | P62333 | |
| GIAVFCEMVQFPGDV | 1091 | Q9BTW9 | |
| GYENTPIMVCVDGIV | 21 | Q9NSJ1 | |
| AGRVEDALCGEMPFQ | 1341 | Q9C0I4 | |
| VPRNDEMVFVCGTNA | 126 | Q8NFY4 | |
| MAEVCPGGLQAAETT | 1211 | Q702N8 | |
| GNFVVDQMCEIGKPE | 611 | O94782 | |
| PGVVTNNMICAGLDR | 206 | O43240 |